Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn’s Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center

BACKGROUND: There is paucity of head-to-head studies comparing the effectiveness of ustekinumab (UST) and adalimumab (ADA) in Crohn’s disease (CD). Here we provide a real-world comparison of these two agents. METHODS: We conducted an ambidirectional cohort study. Each patient included had moderate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Zunirah, Venkata, Krishna, Zhang, Nan, Malik, Talha A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785289/
https://www.ncbi.nlm.nih.gov/pubmed/31636774
http://dx.doi.org/10.14740/gr1194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785289/
https://www.ncbi.nlm.nih.gov/pubmed/31636774
http://dx.doi.org/10.14740/gr1194

Ejemplares similares